FNY Investment Advisers’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

FNY Investment Advisers’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,000	Closed	-$246K	–	903
2023 Q4	$246K	Buy	+15,000	New	+$236K	0.27%	76

FNY Investment Advisers's ORTX Position: Q1 2024 in Review

FNY Investment Advisers sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 15,000 shares — an estimated $246K sold.

FNY Investment Advisers first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $246K in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

FNY Investment Advisers reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
FNY Investment Advisers sold 15,000 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $246K.
FNY Investment Advisers first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
FNY Investment Advisers's Orchard Therapeutics plc American Depositary Shares position peaked at $246K in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on FNY Investment Advisers's 13F filing for Q1 2024, filed 3 May 2024.